These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30623624)

  • 21. Implementing a Clostridium difficile testing algorithm and its effect on isolation duration and treatment initiation: a pre- and post-implementation study.
    Vogelzang EH; Lankelma JM; van Mansfeld R; van Prehn J; van Houdt R
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1071-1076. PubMed ID: 31970532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated Czech guidelines for the laboratory diagnosis of Clostridium difficile infections.
    Krůtová M; Nyč O
    Epidemiol Mikrobiol Imunol; 2018; 67(2):92-95. PubMed ID: 30126287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.
    Könönen E; Rasinperä M; Virolainen A; Mentula S; Lyytikäinen O
    Anaerobe; 2009 Dec; 15(6):261-5. PubMed ID: 19591954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection.
    Crobach MJ; Planche T; Eckert C; Barbut F; Terveer EM; Dekkers OM; Wilcox MH; Kuijper EJ
    Clin Microbiol Infect; 2016 Aug; 22 Suppl 4():S63-81. PubMed ID: 27460910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories.
    Fitzpatrick F; Oza A; Gilleece A; O'Byrne AM; Drudy D;
    J Hosp Infect; 2008 Apr; 68(4):315-21. PubMed ID: 18353502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A European survey of diagnostic methods and testing protocols for Clostridium difficile.
    Barbut F; Delmée M; Brazier JS; Petit JC; Poxton IR; Rupnik M; Lalande V; Schneider C; Mastrantonio P; Alonso R; Kuipjer E; Tvede M;
    Clin Microbiol Infect; 2003 Oct; 9(10):989-96. PubMed ID: 14616740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of Clostridium difficile infections: comparative study of two immuno enzyme assays with confirmation by PCR and culture followed by PCR ribotyping].
    Krůtová M; Matějková J; Zajac M; Hubáček P; Nyč O
    Epidemiol Mikrobiol Imunol; 2014 Jun; 63(2):99-102. PubMed ID: 25025672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.
    Chen S; Gu H; Sun C; Wang H; Wang J
    Infection; 2017 Jun; 45(3):255-262. PubMed ID: 27601055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the introduction of nucleic acid amplification testing on Clostridioides difficile detection and ribotype distribution in Wales.
    Perry MD; White PL; Morris TE
    Anaerobe; 2021 Feb; 67():102313. PubMed ID: 33309680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
    Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.
    Kwon JH; Reske KA; Hink T; Burnham CA; Dubberke ER
    J Clin Microbiol; 2017 Feb; 55(2):596-605. PubMed ID: 27927930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey.
    Adler A; Schwartzberg Y; Samra Z; Schwartz O; Carmeli Y; Schwaber MJ;
    Clin Microbiol Infect; 2014 Nov; 20(11):O904-10. PubMed ID: 24674056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.
    Wilcox MH
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():13-20. PubMed ID: 23121550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey.
    Alcalá L; Marín M; Martín A; Sánchez-Somolinos M; Catalán P; Peláez MT; Bouza E;
    J Hosp Infect; 2011 Sep; 79(1):13-7. PubMed ID: 21741114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
    Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of toxigenic Clostridioides [Clostridium] difficile: Usefulness of two commercially available enzyme immunoassays and a PCR assay on stool samples and stool isolates.
    Legaria MC; Rollet R; Di Martino A; Castello L; Barberis C; Rossetti MA; Guardati MC; Fernández Canigia L; Carloni G; Litterio M; Rocchi M; Anchart EG; Trejo FM; Minnaard J; Klajn D; Predari SC
    Rev Argent Microbiol; 2018; 50(1):36-44. PubMed ID: 28988901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.
    Sandlund J; Estis J; Katzenbach P; Nolan N; Hinson K; Herres J; Pero T; Peterson G; Schumaker JM; Stevig C; Warren R; West T; Chow SK
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.